MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Clinical trials for MALIGNANT PERIPHERAL NERVE SHEATH TUMORS explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT PERIPHERAL NERVE SHEATH TUMORS trials appear
Sign up with your email to follow new studies for MALIGNANT PERIPHERAL NERVE SHEATH TUMORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered immune cells take on childhood cancers in new trial
Disease control Recruiting nowThis early-stage trial tests a treatment where a child's own immune cells are collected, modified to better attack cancer, and given back as a one-time infusion. It is for children and young adults up to age 21 with solid tumors that have come back or not responded to standard th…
Matched conditions: MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated May 16, 2026 23:48 UTC
-
New drug targets Hard-to-Treat cancers missing key gene
Disease control Recruiting nowThis early-stage trial tests an experimental drug, MRTX1719, in adults with advanced solid tumors that have a specific genetic change (loss of the MTAP gene). The study aims to find a safe dose and see if the drug can shrink tumors or slow their growth. About 336 participants wit…
Matched conditions: MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Phase: PHASE1 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 16, 2026 23:47 UTC
-
New hope for kids with relapsed wilms tumor: drug trial opens
Disease control Recruiting nowThis study tests a drug called selinexor in children and young adults whose Wilms tumor or other solid tumors have come back or not responded to treatment. The goal is to see if the drug can shrink or control the tumors. About 45 participants will receive the drug, and doctors wi…
Matched conditions: MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
Global effort to unlock secrets of rare nerve cancer
Knowledge-focused Recruiting nowThis study creates a worldwide database for people with malignant peripheral nerve sheath tumors (MPNST), a rare cancer often linked to the genetic condition neurofibromatosis type 1 (NF1). Researchers will collect medical records, tumor samples, and imaging data from over 1,000 …
Matched conditions: MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Sponsor: Washington University School of Medicine • Aim: Knowledge-focused
Last updated May 16, 2026 23:36 UTC
-
Blood test could spot rare cancer early in NF1 patients
Knowledge-focused Recruiting nowThis study is testing whether a blood test (liquid biopsy) can detect a rare but serious cancer called MPNST earlier than current methods in adults with Neurofibromatosis Type 1 (NF1). Researchers will collect blood samples and surveys from 1,000 participants every six months for…
Matched conditions: MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Sponsor: David Miller • Aim: Knowledge-focused
Last updated May 12, 2026 13:41 UTC